Finance

Lists
605116:SHA
Aurisco Pharmaceutical Co Ltd
CNÂ¥19.54
-2.01%
(-0.40) 1D
Sep 9, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605116...
Open
CNÂ¥19.95
High
CNÂ¥19.95
Low
CNÂ¥19.52
Mkt. cap
8.10B
Avg. vol.
3.70M
Volume
1.95M
Dividend
1.74%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 15, 2026
P/E ratio
21.08
52-wk high
CNÂ¥35.58
52-wk low
CNÂ¥18.09
EPS
CNÂ¥0.93
No. of employees
2K
Open
CNÂ¥19.95
High
CNÂ¥19.95
Low
CNÂ¥19.52
Mkt. cap
8.10B
Avg. vol.
3.70M
Volume
1.95M
Dividend
1.74%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 15, 2026
P/E ratio
21.08
52-wk high
CNÂ¥35.58
52-wk low
CNÂ¥18.09
EPS
CNÂ¥0.93
No. of employees
2K
About Aurisco Pharmaceutical Co Ltd
CEO-
Employees2.03K
FoundedMar 5, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
415.09M
460.42M
389.26M
439.11M
Cost of goods sold
155.52M
213.89M
181.44M
192.56M
Cost of revenue
155.52M
213.89M
181.44M
192.56M
Research and development expenses
41.64M
39.95M
37.70M
39.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.01M
73.27M
79.61M
74.34M
Operating expense
110.35M
126.75M
116.16M
116.05M
Total operating expenses
265.88M
340.64M
297.60M
308.61M
Operating income
149.21M
119.78M
91.66M
130.50M
Other non operating income
-2.85M
5.98M
-13.75M
-30.80M
EBT including unusual items
136.52M
114.22M
77.14M
107.40M
EBT excluding unusual items
141.99M
109.46M
74.49M
108.46M
Income tax expense
17.87M
18.55M
13.21M
12.58M
Effective tax rate
13.09%
16.24%
17.13%
11.71%
Other operating expenses
-6.08M
8.14M
-368.30K
1.72M
Net income
118.64M
95.67M
63.93M
94.82M
Net profit margin
28.58%
20.78%
16.42%
21.59%
Earnings per share
-
-
-
-
Interest and investment income
7.13M
2.72M
5.73M
9.16M
Interest expense
-8.84M
-9.20M
-9.16M
-390.88K
Net interest expenses
-1.72M
-6.48M
-3.43M
8.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
169.55M
149.61M
121.49M
173.21M
Gain or loss from assets sale
75.30K
546.03K
-
-414.39K
AI content may include mistakes. Learn more
Google apps